SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-011410
Filing Date
2024-03-27
Accepted
2024-03-27 09:45:40
Documents
1
Period of Report
2024-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5940
  Complete submission text file 0001493152-24-011410.txt   7416
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address NO. 23 LORONG TERUBONG RIA 2, PAYA TERUBONG GEORGE TOWN N8 11060
Business Address
Choong Choon Hau (Reporting) CIK: 0001986021 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 24786244